Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

10472	Companies
220554	Keywords
149882	Articles
116640	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 04/08/2026 at 00:05, 1 month 22 days ago

Onco-Innovations Expands into Australia with New Subsidiary and Partnership

Clinical Trials Marketing Strategy Oncology Research R&D Incentives Australian Expansion
PRESS RELEASE

published on 04/08/2026 at 00:00, 1 month 22 days ago

Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Onco-Innovations announces engagement with RDI Partners & formation of ONCO AU subsidiary in Australia to support Phase I development activities & potential eligibility for Australia's R&D Tax Incentive program

Australia Onco-Innovations RDI Partners ONCO AU Phase I Development
BRIEF

published on 03/12/2026 at 22:05, 2 months 17 days ago

Onco-Innovations Completes Private Placement Raising $1.2 Million

Private Placement Warrants Capital Raising Research Funding Onco-Innovations
PRESS RELEASE

published on 03/12/2026 at 22:00, 2 months 17 days ago

Onco-Innovations Announces Closing of Private Placement
Onco-Innovations Limited closes non-brokered private placement for $1,215,500, issuing 1,870,000 Units. Proceeds for corporate development and working capital. Securities subject to statutory hold period

Private Placement Securities Working Capital Cancer Research Onco-Innovations Limited
BRIEF

published on 02/12/2026 at 15:05, 3 months 17 days ago

Onco-Innovations Adjusts Pricing for Private Placement

Private Placement Regulatory Compliance Financial Strategy Onco-Innovations Investment Announcement
PRESS RELEASE

published on 02/12/2026 at 15:00, 3 months 17 days ago

Onco-Innovations Announces Amendment to Private Placement Pricing
Onco-Innovations Limited amends pricing for non-brokered private placement, offering 3,076,923 units at $0.65 each with warrants. Proceeds for corporate and working capital purposes

Private Placement Warrants Corporate Funding Onco-Innovations Limited Pricing Amendment
BRIEF

published on 02/05/2026 at 00:05, 3 months 25 days ago

Onco-Innovations Files Preliminary Base Shelf Prospectus

Cancer Research Securities Offering Base Shelf Prospectus Financial Flexibility Onco-Innovations
PRESS RELEASE

published on 02/05/2026 at 00:00, 3 months 25 days ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Onco-Innovations Limited announces filing of preliminary base shelf prospectus with securities regulatory authorities in several provinces for potential future offerings. Company focuses on cancer research and treatment

Forward-looking Statements Cancer Research Securities Offering Base Shelf Prospectus Onco-Innovations Limited
BRIEF

published on 01/24/2026 at 01:05, 4 months 6 days ago

Onco-Innovations Announces $2 Million Private Placement

Private Placement Regulatory Approvals Capital Raising Shares And Warrants Onco-Innovations
PRESS RELEASE

published on 01/24/2026 at 01:00, 4 months 6 days ago

Onco-Innovations Announces Private Placement
Onco-Innovations Limited announces private placement of Units and Admin Fee Shares for potential gross proceeds of $2,000,000 to fund cancer research and treatment endeavors

Private Placement Units Cancer Research Admin Fee Shares Onco-Innovations Limited

Accesswire

Published on 05/30/2026 at 04:00, 8 hours 6 minutes ago

Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 9 hours 26 minutes ago

BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 10 hours 36 minutes ago

Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 11 hours 35 minutes ago

Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 13 hours 6 minutes ago

The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit

View all ACCESSWIRE

EQS Group

Published on 05/29/2026 at 21:42, 14 hours 23 minutes ago

EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 14 hours 36 minutes ago

Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 16 hours 6 minutes ago

Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 16 hours 19 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 16 hours 38 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/29/2026 at 22:00, 14 hours 6 minutes ago

Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 18 hours 6 minutes ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 18 hours 13 minutes ago

Share buyback mandate
Published on 05/29/2026 at 12:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 1 day 1 hour ago

bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market

View all LES ECHOS COMFI WIRE